A Double-Blind Augmentation Study of LEvetiracetam in Obsessive Compulsive Disorder

NCT00299611 Phase 2/Phase 3 TERMINATED

The purpose of this study is to evaluate the effectiveness of Levetiracetam augmentation relative to Placebo in SSRI non-remitters with obsessive compulsive disorder. The hypothesis is that anxiolytic effect of Levetiracetam is more beneficial when adding with a SSRI.

Details

Lead sponsor	Duke University
Phase	Phase 2/Phase 3
Status	TERMINATED
Enrolment	12
Start date	2005-11
Completion	2008-04

Conditions

• Obsessive-Compulsive Disorder

Interventions

• Sertraline
• Levetiracetam
• Placebo

Primary outcomes

• Clinical Global Impression-improvement (CGI-I) — 24 wks

Countries

United States